Most health conditions do not discriminate based on race, color, gender or identity. However, background and identity can make access to health treatment much more difficult.
So, what is this thing we call ‘empathetic technology’? While the two terms seem like antonyms, the intersection is proving to be a rich opportunity for innovation.
The Institute for Clinical and Economic Review (ICER) measures the value of new drugs and health technologies, but faces a number of key challenges such as keeping their assessments up to d
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
